The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II trial of preoperative chemotherapy of S-1/CDDP with or without trastuzumab followed by surgery in HER2 positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger Study).
 
Masanori Tokunaga
Honoraria - Intuitive Surgical; Johnson & Johnson; Kaken Pharmaceutical; Lilly Japan; Medtronic; Olympus Medical Systems; Ono Pharmaceutical; Taiho Pharmaceutical
 
Nozomu Machida
Honoraria - Bristol-Myers Squibb Japan; Daiichi Sankyo; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - MSD (Inst)
 
Junki Mizusawa
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Hiroshi Yabusaki
No Relationships to Disclose
 
Hirofumi Yasui
No Relationships to Disclose
 
Motohiro Hirao
No Relationships to Disclose
 
Masaya Watanabe
No Relationships to Disclose
 
Takushi Yasuda
No Relationships to Disclose
 
Takahiro Kinoshita
No Relationships to Disclose
 
Hiroshi Imamura
No Relationships to Disclose
 
Jun Hihara
No Relationships to Disclose
 
Narikazu Boku
Honoraria - Bristol-Myers Squibb Japan; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst); Takeda (Inst)
 
Tomoko Kataoka
No Relationships to Disclose
 
Takaki Yoshikawa
Honoraria - AstraZeneca; BMS; Chugai Pharma; Daiichi Sankyo; EA Pharma; Johnson & Johnson/Janssen; Medtronic; Miyarisan pharmaceutical; MSD; Ono Pharmaceutical; Taiho Pharmaceutical; TERUMO
Consulting or Advisory Role - MSD Oncology; TERUMO
Research Funding - Lilly
 
Takeshi Sano
Speakers' Bureau - Dai-ichi Sankyo; Johnson & Johnson; Ono Pharmaceutical; Taiho Pharmaceutical
 
Mitsuru Sasako
Honoraria - Daiichi Sankyo; Ono Pharmaceutical; Taiho Pharmaceutical
 
Masanori Terashima
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Lilly; Medtronic; Olympus; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Ono Pharmaceutical (Inst)